X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
J.B.Chemicals Fact Sheet, J.B.Chemicals Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.Chemicals Fact Sheet   (JBCH)

Here is the latest financial fact sheet of J.B.Chemicals. For more details, see the J.B.Chemicals quarterly results and J.B.Chemicals share price and chart. For a sector overview, read our pharmaceuticals sector report.

J.B.CHEMICALS Price History

Price Rs 321.6
Mkt Cap Rs m 27,272
Vol '000 6.8
P/E X 15.8
P/CF X 13.4
EPS (TTM) Rs 20.4
% ch % -0.6
No. of shares m 84.80
% ch week % -0.2
% ch 1-mth % -3.8
% ch 12-mth % 21.8
52 week H/L Rs 403.6/262.3
(As on Jul 21, 2017 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

J.B.CHEMICALS Financials

No. of Mths
Year Ending
12
Mar-12
*
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
J.B.CHEMICALS EQUITY SHARE DATA
High Rs18596142258318 
Low Rs585973129200 
Sales per share (Unadj.) Rs94.7102.2120.6134.9148.0 
Earnings per share (Unadj.) Rs80.09.47.311.819.1 
Diluted earnings per shareRs79.99.47.311.819.1 
Cash flow per share (Unadj.) Rs82.712.310.616.423.9 
Dividends per share (Unadj.) Rs41.003.003.0014.000.50 
Adj. dividends per shareRs40.963.003.0014.000.50 
Dividend yield (eoy) %33.73.92.87.20.2 
Book value per share (Unadj.) Rs114.5120.4123.1117.3128.9 
Adj. book value per shareRs114.4120.3123.0117.3129.0 
Shares outstanding (eoy) m84.7184.7184.7384.8184.82 
Bonus/Rights/Conversions  ESOS-ESOPESOP- 
Price / Sales ratio x1.30.80.91.41.7 
Avg P/E ratio x1.58.314.816.313.6 
P/CF ratio (eoy) x1.56.310.111.810.8 
Price / Book Value ratio x1.10.60.91.62.0 
Dividend payout %51.232.041.3118.32.6 
Avg Mkt Cap Rs m10,2926,5829,07916,38121,951 
No. of employees `0003.52.42.52.22.7 
Total wages/salary Rs m1,1271,3011,4371,5961,841 
Avg. sales/employee Rs Th2,321.53,571.74,120.45,302.24,590.9 
Avg. wages/employee Rs Th326.2536.3579.3739.4673.4 
Avg. net profit/employee Rs Th1,962.7327.6248.0465.3592.1 
J.B.CHEMICALS INCOME DATA
Net Sales Rs m8,0198,66110,21911,44212,551 
Other income Rs m290279377109542 
Total revenues Rs m8,3088,94010,59611,55113,093 
Gross profit Rs m1,0031,0571,4851,7922,055 
Depreciation Rs m224247280386412 
Interest Rs m24053625996 
Profit before tax Rs m8291,0361,5201,4562,088 
Minority Interest Rs m00000 
Prior Period Items Rs m1102100 
Extraordinary Inc (Exp) Rs m7,6060-64500 
Tax Rs m1,666241281451469 
Profit after tax Rs m6,7797956151,0041,619 
Gross profit margin %12.512.214.515.716.4 
Effective tax rate %201.123.318.531.022.5 
Net profit margin %84.59.26.08.812.9 
J.B.CHEMICALS BALANCE SHEET DATA
Current assets Rs m8,6629,4379,8079,0097,778 
Current liabilities Rs m1,8832,3952,7634,5984,358 
Net working cap to sales %84.581.368.938.627.2 
Current ratio x4.63.93.52.01.8 
Inventory Days Days4644484855 
Debtors Days Days6281848480 
Net fixed assets Rs m3,1533,3923,5693,8385,713 
Share capital Rs m169169169170170 
"Free" reserves Rs m9,2149,71110,0379,53110,547 
Net worth Rs m9,70010,20310,4289,94910,937 
Long term debt Rs m12672540 
Total assets Rs m11,97813,00213,51014,87215,574 
Interest coverage x4.420.625.425.522.8 
Debt to equity ratio x00000 
Sales to assets ratio x0.70.70.80.80.8 
Return on assets %58.66.55.07.211.0 
Return on equity %69.97.85.910.114.8 
Return on capital %88.410.69.215.220.0 
Exports to sales %41.353.954.350.648.7 
Imports to sales %8.05.88.48.87.1 
Exports (fob) Rs m3,3084,6645,5465,7876,115 
Imports (cif) Rs m6415028611,006889 
Fx inflow Rs m3,5584,7555,6055,8336,169 
Fx outflow Rs m1,5031,0891,5691,3881,285 
Net fx Rs m2,0553,6654,0374,4454,884 
J.B.CHEMICALS CASH FLOW
From Operations Rs m 8,797 842 -140 1,267 1,397 
From Investments Rs m -2,609 -1,161 -1,425 -1,119 -320 
From Financial Activity Rs m -5,261 -315 120 -14 -1,196 
Net Cashflow Rs m 926 -633 -1,444 134 -102 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 55.4%
Foreign collaborators 0.3%
Indian inst/Mut Fund 3.4%
FIIs 3.9%
ADR/GDR 0.0%
Free float 37.0%
Shareholders 30,437
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Neelam Centre, 4th Floor, B-Wing, Hind Cycle Road, Worli, Mumbai - 400 030
E-MAIL investorelations@jbcpl.com WEB www.jbcpl.com
TELEPHONE (022) 3045 1200 FAX (022) 2493 0534
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Datamatics, No. B-5, MIDC, Part B, Cross Lane, Andheri (E), Mumbai-93
AUDITOR J. K. Shah & Co.
CHM: Durga Dass Chopra COMP SEC: M. C. Mehta YEAR OF INC: 1976 BSE CODE: 506943 FV (Rs): 2 DIV YIELD (%): 0.2

More Pharmaceuticals Company Fact Sheets:   GSK PHARMA  SANOFI INDIA  IPCA LABS  UNICHEM LAB  PIRAMAL ENTERPRISES  

Compare J.B.CHEMICALS With:   GSK PHARMA  SANOFI INDIA  IPCA LABS  UNICHEM LAB  PIRAMAL ENTERPRISES  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Stronger Euro Drags European Markets(RoundUp)

The strength of the euro does appear to be acting as a bit of a headwind for European stocks as they look to close the week sharply lower in contrast to the performance of UK and US stocks this week.

Views on news

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

More Views on News

Most Popular

Post Demonetisation Real Estate Sales Have Collapsed, But Prices Haven't(Vivek Kaul's Diary)

Jul 11, 2017

While sales have fallen dramatically, net net home prices continue to hold on.

Ride the Bull Wave with These Perfect Proxies to India's Growth Story(The 5 Minute Wrapup)

Jul 15, 2017

The secret of spotting multibaggers before they become a hit.

The New Pharma Rally Starts NOW(Daily Profit Hunter)

Jul 12, 2017

The most hated sector is offering the best trading opportunity. Are you ready?

All You Need To Know To e-File Your Income Tax Returns(Outside View)

Jul 12, 2017

The Income Tax return filing deadline is drawing near; if you have not already filed your taxes, here's how to do it.

The Impact of GST On Banking transactions, Insurance, and Investments(Outside View)

Jul 11, 2017

PersonalFN explains how GST impacts your insurance premiums, investments, and banking transactions.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON J.B.CHEMICALS

J.B.CHEMICALS - STERLING BIOTECH COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS